The results give information on the potential ability of huangqin to intervene in ACE2-mediated SARS-CoV-2 infection and provide a scientific foundation for the development of preventive and therapeutic agents from huangqin against COVID-19. The gene discussed is ACE2; the disease is COVID-19.